Skip to main content
LUYAN PHARMA CO.,LTD logo

LUYAN PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 002788 ISIN · CNE1000025W1 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,022 across all filing types
Latest filing 2016-04-27 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002788

About LUYAN PHARMA CO.,LTD

https://www.luyan.com.cn

Luyan Pharma Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive logistics network, providing supply chain management services to healthcare institutions, including hospitals and community clinics. Its product portfolio encompasses a wide range of Western pharmaceuticals, traditional Chinese medicines, and medical equipment. In addition to wholesale distribution, the company maintains a significant presence in the retail pharmacy sector through a chain of drugstores. Luyan Pharma focuses on optimizing healthcare delivery through integrated distribution systems and value-added services, such as third-party logistics and pharmaceutical cold chain management. The organization leverages its regional market leadership to expand its service footprint and enhance the efficiency of the medical supply chain.

Recent filings

Filing Released Lang Actions
关于召开公司2015年年度股东大会的通知的更正公告
AGM Information Classification · 90% confidence The document is a correction notice regarding a previously published announcement about the convening of the 2015 Annual General Meeting (AGM) of the company. It corrects the registration deadline for shareholders to participate in the AGM. The document is short (606 characters) and serves as an announcement or correction to a prior notice rather than the AGM materials themselves. Therefore, it fits best under the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related notices. The correction is directly related to the AGM notice, so AGM-R is the most appropriate classification.
2016-04-27 Chinese
2016年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016年第一季度报告正文" which translates to "2016 First Quarter Report". It contains detailed financial data such as revenue, net profit, cash flow, shareholder information, and management commitments for the first quarter of 2016. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates it is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2016-04-24 Chinese
独立董事2015年度述职报告(翁君奕)
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2015 Annual Work Report" for a company, detailing the independent director's attendance at board and shareholder meetings, opinions on company matters, committee roles, and efforts to protect minority shareholders. It is a narrative report on the independent director's activities and responsibilities during the year 2015. The document is about the director's duties and governance role rather than a financial report, audit, or announcement. It is not a full annual report (10-K), audit report (AR), or management report (MDA). It is also not a proxy statement or voting result announcement. The content fits best with Board/Management Information (MANG) as it relates to board member activities and governance roles. The document length is 2594 characters, which is relatively short but contains substantive content about board member duties rather than just an announcement or certification. Therefore, the classification is MANG with high confidence.
2016-04-24 Chinese
独立董事2015年度述职报告(吴俊龙)
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2015, detailing attendance at board and shareholder meetings, opinions on company matters, committee roles, and efforts to protect minority shareholders. It is a narrative report on the director's duties and activities rather than a full annual report or financial statement. The document length is 2553 characters, which is relatively short and focused on director duties and governance rather than financial data. It does not contain financial statements or audit results, so it is not an Annual Report (10-K) or Audit Report (AR). It is not a regulatory filing or announcement but a management-related report on board activities. Therefore, the best fit is Board/Management Information (MANG), which covers announcements of changes or reports related to board or senior management activities.
2016-04-24 Chinese
2015年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2015 年度内部控制自我评价报告' which translates to '2015 Annual Internal Control Self-Evaluation Report'. It is issued by the company's board of directors and discusses the internal control evaluation for the fiscal year ending December 31, 2015. The content includes detailed descriptions of the company's internal control environment, risk assessment, control activities, information systems, and supervision. It also includes the evaluation criteria for internal control deficiencies and the conclusion that no major deficiencies were found. The document is comprehensive and contains substantive information about internal controls, which is typical of an Audit Report or Information related to internal control effectiveness. It is not an Annual Report (10-K) as it does not cover full financial performance or business activities broadly, nor is it a simple announcement or certification. It is not a Management Report or Earnings Release. The focus on internal control evaluation and the detailed nature aligns with the category of Audit Report / Information (AR). The document length (over 14,000 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is AR with high confidence.
2016-04-24 Chinese
关于公司控股股东及其他关联方占用资金情况的专项说明
Regulatory Filings
2016-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.